These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Melatonin in Alzheimer's Disease: A Latent Endogenous Regulator of Neurogenesis to Mitigate Alzheimer's Neuropathology. Hossain MF; Uddin MS; Uddin GMS; Sumsuzzman DM; Islam MS; Barreto GE; Mathew B; Ashraf GM Mol Neurobiol; 2019 Dec; 56(12):8255-8276. PubMed ID: 31209782 [TBL] [Abstract][Full Text] [Related]
9. The Involvement of Melatonin and Tasimelteon against Alzheimer's Disease. Ravikumar M; Mohan S; Velpandian C Curr Drug Saf; 2023; 18(3):284-296. PubMed ID: 35585820 [TBL] [Abstract][Full Text] [Related]
10. Melatonin and Autophagy in Aging-Related Neurodegenerative Diseases. Luo F; Sandhu AF; Rungratanawanich W; Williams GE; Akbar M; Zhou S; Song BJ; Wang X Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998479 [TBL] [Abstract][Full Text] [Related]
11. Role of Melatonin in Aluminum-Related Neurodegenerative Disorders: a Review. Esparza JL; Gómez M; Domingo JL Biol Trace Elem Res; 2019 Mar; 188(1):60-67. PubMed ID: 29732485 [TBL] [Abstract][Full Text] [Related]
12. Melatonin Attenuates Memory Impairment, Amyloid-β Accumulation, and Neurodegeneration in a Rat Model of Sporadic Alzheimer's Disease. Rudnitskaya EA; Muraleva NA; Maksimova KY; Kiseleva E; Kolosova NG; Stefanova NA J Alzheimers Dis; 2015; 47(1):103-16. PubMed ID: 26402759 [TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of melatonin in experimental models of Alzheimer disease. Cheng Y; Feng Z; Zhang QZ; Zhang JT Acta Pharmacol Sin; 2006 Feb; 27(2):129-39. PubMed ID: 16412260 [TBL] [Abstract][Full Text] [Related]
14. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. Dragicevic N; Copes N; O'Neal-Moffitt G; Jin J; Buzzeo R; Mamcarz M; Tan J; Cao C; Olcese JM; Arendash GW; Bradshaw PC J Pineal Res; 2011 Aug; 51(1):75-86. PubMed ID: 21355879 [TBL] [Abstract][Full Text] [Related]
15. Antioxidants and neuroprotection in the adult and developing central nervous system. Kaur C; Ling EA Curr Med Chem; 2008; 15(29):3068-80. PubMed ID: 19075654 [TBL] [Abstract][Full Text] [Related]
16. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease. Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969 [TBL] [Abstract][Full Text] [Related]
17. Recent developments of melatonin related antioxidant compounds. Suzen S Comb Chem High Throughput Screen; 2006 Jul; 9(6):409-19. PubMed ID: 16842222 [TBL] [Abstract][Full Text] [Related]
18. Melatonin Therapy in Patients with Alzheimer's Disease. Cardinali DP; Vigo DE; Olivar N; Vidal MF; Brusco LI Antioxidants (Basel); 2014 Apr; 3(2):245-77. PubMed ID: 26784870 [TBL] [Abstract][Full Text] [Related]
19. Melatonin and Parkinson's disease. Mayo JC; Sainz RM; Tan DX; Antolín I; Rodríguez C; Reiter RJ Endocrine; 2005 Jul; 27(2):169-78. PubMed ID: 16217130 [TBL] [Abstract][Full Text] [Related]
20. The use of melatonin in Alzheimer's disease. Cardinali DP; Brusco LI; Liberczuk C; Furio AM Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]